TOG Review (RCOG Journal)

MRCOG Part 2

Gynaecological Problems

Metabolic syndrome in women with polycystic ovary syndrome

Key Statistics

  • 33% — Prevalence of metabolic syndrome in PCOS
  • 10–18% — PCOS prevalence, reproductive age
  • 5–10% — Target weight loss, year 1

Don't-miss facts

  1. Metabolic syndrome affects 33% of PCOS; JIS (2009) criteria = ≥3 of 5 (waist circumference, triglycerides, HDL-C, BP, fasting glucose)

  2. PCOS doubles CHD/stroke risk (55% increase after BMI adjustment); metabolic syndrome → 5-fold diabetes type II risk

  3. PCOS → up to 30-fold ↑OSA risk and depression OR 4.03 (independent of BMI) – screen and refer

  4. Endometrial cancer risk: PCOS OR 2.89; metabolic syndrome OR 1.6

  5. Lifestyle modification (5–10% weight loss year 1; 150 min/week exercise, 90 min moderate aerobic) is the only universally recommended intervention

  6. Metformin (500–1500 mg/day) only evidence-supported in IGT to prevent diabetes progression, not for IR alone in normoglycaemic women

  7. Statins reserved for dyslipidaemia only – teratogenic risk in reproductive-age women

  8. Bariatric surgery threshold: BMI ≥40, or BMI 35–39.9 with comorbidity (diabetes/hypertension); reduced PCOS incidence from 45.6% to 6.8% at 12 months in one meta-analysis

Diagnostic definitions at a glance

Central obesity-based: NCEP:ATP III, AHA/NHLBI, IDF, JIS Insulin resistance-based (historic): WHO, EGIR, AACE

Abbreviation Key

  • PCOS — polycystic ovary syndrome
  • AACE — American Association of Clinical Endocrinology
  • IR — insulin resistance NCEP:ATP
  • III — National Cholesterol Education Program Adult Treatment Panel III
  • CVD — cardiovascular disease
  • AHA/NHLBI — American Heart Association/National Heart, Lung,
  • CHD — coronary heart disease and Blood Institute
  • BMI — body mass index
  • IDF — International Diabetes Federation
  • OSA — obstructive sleep apnoea
  • JIS — Joint Interim Statement
  • IGT — impaired glucose tolerance
  • MI — myoinositol
  • OR — odds ratio
  • DCI — d-chiro-inositol
  • WHO — World Health Organization
  • GLP-1R — glucagon-like peptide-1 receptor
  • EGIR — European Group for the study of Insulin Resistance

Source: Metabolic syndrome in women with polycystic ovary syndrome. The Obstetrician & Gynaecologist 2018;20:245–252. doi:10.1111/tog.12519

MRCOG AI is an independent educational tool. It is not affiliated with, endorsed by, or connected to the Royal College of Obstetricians and Gynaecologists (RCOG).

Included with a Pass Package

  • Audio overview of this guideline
  • Practice questions drawn from it
  • AI tutor answers grounded in its text
  • Your own annotations
Start free